OTHERAPPROVED

TransCode Funds Metastatic Cancer Therapeutics Research

Michigan State University’s Board of Trustees approved acceptance of a $2,100,945 new research award from TransCode Therapeutics Inc to the Department of Radiology Human Medicine. The five-year project will support development of TTX-based therapeutics for metastatic cancer through 2031.

Document date · June 12, 2026

Track Michigan State University contracts

Get alerts when new contracts are awarded or existing ones approach renewal at Michigan State University.

Get started free

Create a free account · no credit card

Trusted by 200+ enterprise customers and 1,000+ teams on the free plan

Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo
Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo
Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo
Motive logo
Veritone logo
TerraCycle logo
Cyvl logo
WithersRavenel logo
Derivita logo
Comcate logo
SafeTouch logo
IANS Research logo

Scope & details

The full contract record, as filed.

Contract amount
$2,100,945
Contract type
OTHER
Contract term
04/11/2026 – 04/10/2031
Renewal date
2031-04-10
Renewal
New multi‑year sponsored research award; any renewals or extensions would depend on future sponsor actions and are not specified in the report.
Document type
Report
Source document
Michigan State University Gift, Grant and Contract Report 2026-06-12

Frequently asked questions

Common questions about this contract, answered from the record.

Who was awarded the government contract by Michigan State University?

Transcode Therapeutics Inc was awarded this government contract by Michigan State University, as recorded on June 12, 2026. The contract value is $2,100,945.

How much is the Transcode Therapeutics Inc contract with Michigan State University worth?

The Transcode Therapeutics Inc contract with Michigan State University is valued at $2,100,945.

What type of contract is this?

This is a government contract, documented as a report record.

Where was this contract approved?

This contract appears in Michigan State University Gift, Grant and Contract Report 2026-06-12 (Report), dated June 12, 2026 from Michigan State University. Civic IQ extracts contract records directly from agency meeting documents and solicitations.

What other contracts does Transcode Therapeutics Inc hold?

Transcode Therapeutics Inc may hold additional government contracts. View their full contract history, the agencies they serve, and total tracked spend on their Civic IQ vendor profile.

View Transcode Therapeutics Inc's profile

What is Michigan State University currently buying?

Explore Michigan State University's vendors, signed contracts, and active RFPs on their Civic IQ agency profile.

View Michigan State University's profile